Nearly half of cancer deaths due to smoking-attributable cancers
the ONA take:
Researchers from the American Cancer Society updated estimates of cancer-related deaths from smoking. The new numbers indicate an estimated 48.5% of the nearly 346,000 deaths from 12 cancers among adults 35 years and older were attributable to cigarette smoking.
The researchers used data from the 2011 National Health Interview Survey, the Cancer Prevention Study III, and the pooled contemporary cohort.
The results show that of an estimated 345,962 deaths, 167,805 were attributable to smoking cigarettes. Cancers of the lung, bronchus, and trachea and cancer of the larynx made up the largest proportion of smoking-attributable deaths: 80.2% and 76.6%, respectively.
In addition, approximately half of deaths from cancers of the oral cavity, esophagus, and urinary bladder were attributable to smoking.
The authors conclude that further progress in reducing cancer mortality will depend on more comprehensive tobacco control, including targeted cessation support.
An estimated 48.5% of the nearly 346,000 deaths from 12 cancers among adults 35 years and older were attributable to cigarette smoking.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|